BEIJING -- Xu Qiliang, vice chairman of China's Central Military Commission, has stressed building a strong and modernized maritime law enforcement force.Xu, also a member of the Political Bureau of the Communist Party of China Central Committee, made the remarks while extending his Spring Festival greetings to officers and soldiers at the headquarters of the Chinese Coast Guard under the armed police.Asking about the ongoing patrols on the East China Sea and the South China Sea, Xu required the officers and soldiers to be well-prepared for different cases, encouraging them to staunchly safeguard China's maritime rights and interests.He called for solid practices to further develop the coast guard force, noting that it concerns the overall strategy of building China into a maritime power.Xu also stressed steadily enhancing the coast guard's readiness to safeguard maritime rights and enforce the law on the sea and improving their capability to deal with related risks and challenges. wristbands canadacustom silicone bracelets canadarubber bracelets canadasilicone bracelets canadasilicone wristbands canadacustom wristbands canadacanadian wristbandswristbands canada
[Photo/VCG] BEIJING -- China has unveiled a pilot medicine procurement program to be tried in 11 major cities to lower drug prices and reduce the burden on patients. Details of the program was released by the General Office of the State Council Thursday. As a major reform of the current centralized procurement system, the program asks public hospitals in the pilot cities to purchase 60 to 70 percent of their total annual demand for certain medicines in order to get a lower price. Previously, the bidding usually only determined the price, but could not guarantee the purchase quantity. The pilot program aims to cut drug prices, reduce medicine costs for patients and transaction costs for enterprises, and improve the ecology of the pharmaceutical industry, said the official document. The 11 cities, including Beijing, Shanghai, Guangzhou and Shenzhen, account for about one-third of the national medicine market.
